In addition, patients expressing aberrant splicing products of MYH14 develop myotonic dystrophy type 1 (DM1), a progressive multisystem genetic disorder that affects 1 in 8000 people worldwide (Rinaldi et al., 2012; Kumar et al., 2013). This evidence concerns the gene MYH14 and myotonic dystrophy type 1.